title: [The effect of Recormon therapy on the quality of life of patients on hemodialysis treatment].
abstract: Recormon was given to 34 patients on hemodialysis. The drug's effects on quality of life were judged by the results of clinical, laboratory, experimental and psychological dynamic investigations. The highest effect occurred on the therapy month 6-12. Recormon contributed to relief of asthenic and depressive syndromes, to an increase of activity and improvement of well-being, quality of life by Karnofsky scale within the first year of treatment. The dynamics of life quality changes depended on initial psycho-physical condition of the patients, the age, blood pressure, hematocrit. Recormon treatment is associated with the risk of euphoria.
authors.forename: S I
authors.initials: SI
authors.lastname: Riabov
authors.forename: G D
authors.initials: GD
authors.lastname: Shostka
authors.forename: N N
authors.initials: NN
authors.lastname: Petrova
authors.forename: I A
authors.initials: IA
authors.lastname: Vasil'eva
authors.forename: A N
authors.initials: AN
authors.lastname: Vasil'ev
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D017567:Karnofsky Performance Status; D007676:Kidney Failure, Chronic / Q000097:blood / Q000523:psychology / Q000628:therapy; D008950:MMPI; D008297:Male; D011788:Quality of Life; D011994:Recombinant Proteins; D012044:Regression Analysis; D006435:Renal Dialysis / Q000379:methods / Q000523:psychology / Q000706:statistics & numerical data; D013997:Time Factors
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin